Novel Coronavirus Pneumonia (COVID-19)
Conditions
Sponsors
Hebei Province Chest Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Asymptomatically infected with novel coronavirus pneumonia discovered through pathogenic testing; 2. Over 18 years old (including 18 years old); 3. Voluntarily sign a written informed consent before the study begins.
Exclusion criteria
Exclusion criteria: 1. Patients with new coronavirus pneumonia confirmed by pathogenic testing and clinical manifestations or signs; 2. In the opinion of the investigatorpatients with serious diseases such as malignant disease, autoimmune disease, liver and kidney disease, blood disease, neurological disease, and endocrine disease may affect patients' participation in the trial or influence the outcome of the study; 3. Pregnant or lactating women; 4. Patients who participated in other clinical trials within the last 3 months; 5. An allergic condition, such as a history of allergies to two or more drugs or foods, or a known allergy to the ingredients of the drug; 6. The investigator believes that there are any factors that are not suitable for enrollment or affect the evaluation of the efficacy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time and rate of nucleic acid turning negative during the isolation observation period; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms and severity during the isolation observation period;Clinical symptoms appearance time and proportion during the isolation observation period;Proportion of mild and common cases of novel coronavirus pneumonia diagnosed during the isolation observation period; | — |
Countries
China
Contacts
Public ContactLiu Qingquan/Mei Jianqiang/Wu Shucai
Hebei Province Chest Hospital
Outcome results
None listed